Related Experiment Video
Updated: Jan 15, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Correction: NGLY1 deficiency - clinical features and therapeutic strategy
Haruhiko Fujihira1,2, Hiroto Hirayama3,4, Tadashi Suzuki5
1Glycometabolic Biochemistry Laboratory, Pioneering Research Institute, RIKEN, Wako, Saitama, Japan. haruhiko.fujihira@riken.jp.
No abstract available in PubMed .
More Related Videos
18:08Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Related Concept Videos
Hypoglycemia and Glucagon
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Lysosomal Hydrolases
Inborn Errors of Metabolism